Available datapackage for study 'The Effect of Dulaglutide on Major Cardiovascular Events in Patients With Type 2 Diabetes: Researching Cardiovascular Events With a Weekly INcretin in Diabetes (REWIND)'

The purpose of this trial is to assess whether dulaglutide can reduce major cardiovascular
events and other serious outcomes in persons with type 2 diabetes, when added to their
anti-hyperglycemic regimen.

本临床试验旨在评估，在2型糖尿病患者的现有抗高血糖治疗方案基础上加用度拉糖肽（dulaglutide）时，是否能够降低其主要心血管事件及其他严重不良结局的发生风险。